Introduction to CT enterography in inflammatory bowel disease

The CT enterography protocol has become the dominant cross-sectional technique for evaluating the small bowel in patients with suspected or known inflammatory bowel disease (IBD). Unlike a routine abdominal CT, CT enterography is purpose-built to distend the jejunum and ileum with a large volume of neutral oral contrast, then capture peak mural enhancement during a tightly timed intravenous phase. This combination allows radiologists to see beyond the mucosal surface visible at endoscopy and characterize the full thickness of the bowel wall, the surrounding mesentery, and the vasa recta supplying each segment.

For radiographers, the protocol is unforgiving of shortcuts: inadequate oral contrast distention or a mistimed intravenous bolus can render an otherwise normal bowel loop indistinguishable from active Crohn’s disease, or conversely mask a genuine stricture^[3]. For radiologists, the differential spans benign self-limited entities through to small bowel malignancy, and the consequences of a missed fistula or undiagnosed obstruction are significant. For the referring gastroenterologist or emergency physician, CT enterography findings frequently determine whether a patient proceeds to biologic therapy escalation, urgent surgical consultation, or simple outpatient follow-up.

Successful execution of this examination is genuinely a team effort. The technologist’s diligence in achieving adequate bowel distention sets the ceiling for everything that follows; the radiologist’s systematic, segment-by-segment review pattern determines how much of that diagnostic potential is actually realized in the report; and the referring physician’s correct clinical correlation determines whether the report’s findings translate into the right next step for the patient. Weakness at any one of these three links in the chain can undermine the value of careful work performed at the other two, which is precisely why this guide treats all three perspectives as equally essential rather than focusing narrowly on technique alone.

This guide walks through the full CT enterography protocol from patient preparation to report dictation, with dedicated sections on anatomy, scanning technique, contrast administration, radiation dose, the ten most clinically significant pathologies, and — critically — the distinct pitfalls that trip up radiographers, radiologists, and non-radiology physicians differently. Understanding these three perspectives side by side is one of the fastest ways for a multidisciplinary team to reduce diagnostic error in IBD imaging.

Inflammatory bowel disease affects a meaningful and, in many regions, rising proportion of the population, with both Crohn’s disease and ulcerative colitis most commonly diagnosed in adolescence and early adulthood. Because onset occurs early in life and the disease course is typically chronic and relapsing, affected patients frequently undergo repeated cross-sectional imaging — sometimes spanning several decades — to assess disease extent, monitor treatment response, and screen for complications such as stricture, fistula, abscess, or malignant transformation. This lifetime imaging burden is precisely why radiation dose stewardship, discussed in detail later in this guide, carries particular weight in this specific patient population compared with many other indications for body CT.

Anatomy and Hounsfield unit reference values

A confident interpretation of any CT enterography protocol study depends on a working knowledge of normal small bowel anatomy and the density ranges that separate physiological appearances from disease. The small intestine spans roughly six to seven meters from the duodenojejunal flexure to the ileocecal valve, conventionally divided into duodenum, jejunum, and ileum. On enterography, the jejunum is identified by its thicker, more numerous valvulae conniventes in the left upper quadrant, while the ileum — the segment most frequently involved in Crohn’s disease — has a smoother mucosal contour and lies predominantly in the pelvis and right lower quadrant, terminating at the ileocecal valve.

Gross anatomy relevant to enterography interpretation

The bowel wall itself is composed of mucosa, submucosa, muscularis propria, and serosa. On a well-distended, optimally enhanced CT enterography study, the normal wall measures 1–2 mm and is often imperceptible against the bright, contrast-filled lumen^[1]. The mesentery — a fan-shaped fold of peritoneum carrying the vasa recta, lymphatics, and mesenteric fat — is best assessed on coronal reformats, where engorgement of the vasa recta (the so-called comb sign) becomes most conspicuous. The terminal ileum, ileocecal valve, and adjacent cecum form a critical anatomic triad in Crohn’s disease, since this is the single most common site of disease onset and the area most often biopsied at colonoscopy for correlation.

The mesenteric vasculature follows a predictable arcade pattern from the superior mesenteric artery, and recognizing the normal vasa recta caliber is essential before labeling a segment as having a positive comb sign. Lymph nodes within the mesenteric root are frequently reactive in active IBD and should be distinguished from the firm, often larger nodes associated with lymphoma or carcinoid tumor, which tend to show greater enhancement and a more rounded, less elongated morphology.

Clinical anatomy sub-section: the terminal ileum and ileocecal valve

Because the terminal ileum is the most frequent site of Crohn’s disease, radiographers should ensure this region is fully distended and free of motion before the radiologist begins review. The ileocecal valve can normally appear thickened and lipomatous in older patients, which must not be confused with an active inflammatory mass. Coronal and sagittal reformats through this region, combined with the axial source images, allow confident differentiation between true wall thickening and a prominent but benign ileocecal valve.

Mesenteric vascular anatomy and the vasa recta

The mesenteric vasculature supplying the small bowel arises from the superior mesenteric artery, which gives off a series of jejunal and ileal branches that form an arcading network before terminating as the vasa recta — the short, straight terminal vessels that penetrate the bowel wall directly. In health, these vessels are slender and barely perceptible on a standard enteric-phase acquisition. When a segment becomes actively inflamed, increased blood flow to that segment produces visible engorgement and crowding of the vasa recta on the mesenteric border, producing the comb-like appearance that gives the comb sign its name. Recognizing the normal caliber of these vessels in an uninvolved segment of the same patient is one of the most reliable internal controls available to the interpreting radiologist, since vessel caliber can vary meaningfully between individuals based on body habitus and overall mesenteric vascularity.

The superior mesenteric vein runs parallel to the artery and should also be assessed for patency, particularly in patients with long-standing or penetrating disease, since mesenteric venous thrombosis is a recognized, if uncommon, complication of severe transmural inflammation. Coronal reformats through the root of the mesentery are the most efficient way to trace both the arterial and venous mesenteric anatomy in a single pass.

Mesenteric lymph nodes: reactive versus pathologic

Mild, reactive mesenteric lymphadenopathy is an extremely common accompaniment to active small bowel inflammation and should not, by itself, be treated as a red flag finding. Reactive nodes in IBD are typically oval, retain a preserved fatty hilum, and measure under 10 mm in short axis. Nodes that are rounded rather than oval, lack a fatty hilum, demonstrate marked or heterogeneous enhancement, or cluster into a confluent mass should prompt consideration of an alternative diagnosis such as lymphoma, particularly in a patient whose clinical trajectory does not otherwise fit a typical inflammatory pattern. Correlating nodal appearance with the overall distribution and activity of bowel wall findings — rather than evaluating nodes as an isolated feature — remains the most reliable way to avoid both under- and over-interpretation.

Segment-by-segment anatomic review on CT enterography

A systematic, segment-by-segment review pattern — beginning at the duodenojejunal flexure and tracing the small bowel in continuity through to the ileocecal valve — is the most reliable way to avoid missing a short-segment or skip lesion, both of which are characteristic of Crohn’s disease. Many radiologists supplement this with a dedicated second pass focused specifically on the mesenteric root, the terminal ileum, and the perianal soft tissues when pelvic coverage is included, since penetrating complications such as fistulae and abscesses are easily overlooked on a single, linear review pass through the bowel lumen alone.

Histology-imaging correlation: why the wall layers matter

Understanding the histologic basis of mural stratification helps explain why this single sign carries such diagnostic weight. In active inflammation, edema accumulates preferentially within the submucosal layer, producing a relatively low-attenuation band sandwiched between a brighter, hyperenhancing mucosal layer and a separately enhancing muscularis propria — the so-called target sign or mural stratification pattern. This three-layered appearance is a relatively specific marker of active, edematous inflammation and tends to fade as disease transitions toward chronic fibrosis, at which point the wall becomes more uniformly thickened without the same degree of layered differentiation. Recognizing this distinction allows the radiologist to comment not only on whether disease is present but on whether it appears predominantly active or predominantly fibrotic — a distinction with direct treatment implications, since fibrotic strictures generally do not respond to anti-inflammatory biologic therapy in the way that actively inflamed segments often do.

Normal anatomic variants that can confound interpretation

Several normal anatomic variants are worth keeping in mind specifically because they can be mistaken for pathology on an enterography study performed without prior cross-sectional comparison. Intestinal malrotation, while uncommon in adults presenting for IBD evaluation, alters the expected position of the duodenojejunal flexure and the relationship between the small bowel and the mesenteric vessels, which can make the standard segment-tracing approach more difficult and should prompt a more deliberate, vessel-anchored review strategy. Duplication cysts, though rare, present as cystic structures intimately associated with the bowel wall and can mimic an abscess or a fluid-filled diverticulum if their characteristic well-defined, non-enhancing cystic wall is not specifically recognized. A prominent but otherwise unremarkable appendix, particularly if fluid-distended, occasionally raises unnecessary concern for appendicitis on a study performed for an unrelated indication; correlating with the clinical presentation and confirming the absence of associated periappendiceal fat stranding or wall hyperenhancement typically resolves this ambiguity quickly.

Scanning technique: step-by-step CT enterography protocol

Executing a reproducible CT enterography protocol requires careful sequencing of patient preparation, oral contrast administration, positioning, and intravenous timing. The seven steps below reflect current departmental practice across high-volume gastrointestinal imaging centers, consistent with published technical performance standards^[20].

1. Patient preparation and fasting. Patients fast for 4–6 hours prior to the examination to ensure the stomach is empty and to maximize compliance with the oral contrast load. Diabetic patients and those with gastroparesis require modified timing in consultation with the requesting physician. Clear verbal and written instructions about the volume of oral contrast to be ingested help set expectations and reduce the likelihood of early termination of drinking, which is one of the most common avoidable causes of an under-distended study.
2. Neutral oral contrast administration. Approximately 1,350–1,800 mL of a neutral, low-density agent such as Volumen or a 2.5% mannitol solution is administered in divided doses over 45–60 minutes before scanning^[6]. The neutral density is essential — this is not a barium study. Dividing the volume into three or four smaller servings rather than asking the patient to drink the entire amount at once improves tolerance and reduces the rate of nausea-related early termination, particularly in patients who are already symptomatic from active disease.
3. Optional antiperistaltic agent. Intravenous or intramuscular glucagon may be given immediately before scanning at some institutions to reduce peristaltic blurring of the small bowel wall, improving conspicuity of subtle mucosal findings. Where glucagon is contraindicated or unavailable, simply minimizing delay between final patient positioning and acquisition helps limit motion-related degradation of mural detail.
4. Patient positioning and topogram. The patient is positioned supine (occasionally prone for problem-solving), centered precisely at isocenter, with arms raised above the head to minimize streak artifact across the abdomen and pelvis. Accurate centering is particularly important for automatic exposure control systems, which rely on consistent patient geometry to correctly modulate tube current along the length of the scan.
5. IV line placement and scanogram review. A high-flow intravenous line (typically 18–20 gauge) is secured, and the topogram is reviewed to confirm bowel distention before committing to the contrast bolus — if loops appear collapsed, additional oral contrast or a short delay should be considered. This single quality checkpoint, performed consistently, prevents the single most common avoidable cause of a non-diagnostic study: proceeding to the intravenous phase despite obviously inadequate luminal distention on the topogram.
6. Single-phase enteric/portal venous acquisition. The intravenous bolus (110 mL at 4.0 mL/s) is injected with a 100 mL saline chaser, and the single diagnostic acquisition is obtained at a fixed 50-second delay, targeting peak mural and mesenteric vascular enhancement. Maintaining consistent injector programming across every technologist and every shift is the single greatest lever available for reducing inter-examination variability in enhancement pattern.
7. Reformatting and quality review. Coronal and sagittal multiplanar reformats are generated at the scanner console before the technologist releases the study, allowing an immediate visual check that all small bowel segments are adequately distended and free of significant motion artifact. Any segment that remains ambiguous on this console-side review should prompt a brief discussion with the supervising radiologist before the patient leaves the department, since a same-visit supplementary acquisition is far more efficient than a fully repeated examination on a different day.

Troubleshooting common technical challenges

Several recurring scenarios warrant specific troubleshooting strategies. Patients who cannot tolerate the full oral contrast volume because of severe nausea, odynophagia, or a high-grade stricture may still yield a diagnostically useful study if the technologist documents the actual volume ingested and flags the limitation clearly for the radiologist, who can then weight interpretation accordingly. Patients with an ileostomy or prior bowel resection require an individualized approach to oral contrast timing, since transit time through a surgically altered bowel can differ substantially from an intact gastrointestinal tract. In patients with a high-grade small bowel obstruction, oral contrast administration may be contraindicated altogether because of aspiration risk or the possibility of precipitating a complete obstruction; in this scenario, the contrast-enhanced intravenous phase alone, without an oral contrast load, may be the safer and still clinically useful alternative, with the limitation explicitly noted in the technologist’s worksheet and the final report.

Patient communication and preparation tips

Patient cooperation during the oral contrast ingestion phase has an outsized influence on final study quality, and a few simple communication strategies meaningfully improve compliance. Explaining to the patient, in plain language, why the large fluid volume is necessary — that it is not simply a generic bowel preparation but a specific technique to inflate and visualize the small bowel — tends to improve tolerance compared with a purely procedural instruction sheet. Offering the contrast chilled, when departmental policy and agent stability allow, and pacing the ingestion across the full window rather than asking the patient to finish quickly, both reduce the likelihood of early termination due to bloating or nausea. For patients undergoing repeat surveillance studies, briefly acknowledging that they have done this before and asking whether anything was particularly difficult on a prior visit can surface practical issues — such as a specific flavor that was poorly tolerated — that a generic instruction sheet would not capture.

Beyond raw rotation speed and detector row count, coverage and field-of-view selection matter considerably for enterography specifically. Because relevant pathology can occur anywhere from the duodenojejunal flexure to the rectum — including pelvic small bowel loops, the terminal ileum, and, in some protocols, the perianal soft tissues — the acquisition must reliably include the full abdomen and pelvis rather than a more limited upper-abdominal field of view sometimes used for other indications. Wider-coverage scanner platforms reduce the practical risk of inadvertently truncating the field of view, but ultimately this is a protocol-selection and technologist-vigilance issue rather than a hardware limitation unique to any particular scanner generation.

Dual-energy and photon-counting CT enterography protocols

Spectral CT technologies are increasingly applied to small bowel imaging because virtual monoenergetic reconstructions and iodine maps can improve conspicuity of mural hyperenhancement while permitting a measurable reduction in administered iodine load — a meaningful benefit for IBD patients who undergo serial, lifelong surveillance imaging.

Deep learning reconstruction (DLR) in CT enterography

Deep learning reconstruction algorithms are now deployed across many enterography protocols to suppress quantum noise at lower radiation dose without the blotchy texture associated with older iterative reconstruction methods^[28]. For a young IBD population who may require dozens of surveillance scans over a lifetime, DLR-enabled dose reduction of 30–50% relative to filtered back-projection baselines represents one of the most clinically meaningful technical advances of the past five years, while preserving the edge sharpness needed to characterize subtle mural stratification^[27].

Contrast media protocol for CT enterography

CT enterography relies on a deliberate two-contrast strategy: a large-volume neutral oral agent to distend the bowel lumen, paired with a precisely timed intravenous iodinated bolus to generate mural and mesenteric enhancement. Both components must be correct for the study to be diagnostic — a perfect IV bolus cannot compensate for collapsed, underdistended bowel, and vice versa.

The 50-second fixed delay is chosen deliberately rather than using bolus tracking, because the diagnostic target — mural and mesenteric enhancement — occurs over a broader temporal window than the arrival of contrast in a single vessel of interest^[6]. A fixed enteric-to-early portal venous phase reliably captures both the bright mucosal hyperenhancement of active disease and adequate solid-organ enhancement for incidental findings, without the added complexity of region-of-interest bolus tracking software.

Special population considerations

Pediatric and adolescent patients with IBD require weight-based adjustment of both the oral and intravenous contrast volumes, along with proportionate dose reduction, since this population represents the group most likely to accumulate significant cumulative radiation exposure over a lifetime of surveillance imaging. Pregnant patients with suspected IBD complications should be triaged toward MR enterography or ultrasound wherever clinically feasible, reserving CT enterography for situations where the diagnostic urgency outweighs the radiation and gadolinium-avoidance considerations. Patients with a known prior contrast reaction require premedication per institutional protocol or, where appropriate, referral to MR enterography as a contrast-free or gadolinium-based alternative. Elderly patients and those with reduced renal reserve benefit from a pre-scan eGFR check and, where borderline, consideration of a reduced iodine load using the dual-energy or photon-counting strategies described in the technique section above.

Why neutral contrast — not barium — is non-negotiable

It is worth restating explicitly why the choice of oral agent is so consequential. Positive (barium-based) oral contrast agents were the historical standard for small bowel fluoroscopic studies, where the goal was to outline the lumen in maximal density contrast against the surrounding soft tissue. CT enterography inverts this goal entirely: the diagnostic target is the wall itself, not the lumen, and a dense intraluminal agent obscures the subtle density differences between normal and hyperenhancing mucosa. This single conceptual distinction — luminal opacification versus mural visualization — is the reason CT enterography protocols specify neutral, not positive, oral contrast, and it is the most common point of confusion for staff more familiar with general abdominal CT protocols that do call for positive oral contrast.

Relative and absolute contraindications

Beyond the standard iodinated contrast screening described above, a small number of additional considerations apply specifically to the oral contrast component of CT enterography. Patients with known or suspected high-grade bowel obstruction, severe active toxic megacolon, recent bowel perforation, or significant dysphagia with aspiration risk may not be appropriate candidates for the standard large-volume oral contrast load, and an individualized discussion between the radiologist and the referring clinician is warranted before proceeding in these scenarios. In most other circumstances, however, the standard neutral oral contrast protocol described here is well tolerated, and outright contraindication to the oral component is considerably less common than simple practical intolerance due to nausea or early satiety.

Iodine concentration and injector selection

Selection of a specific iodine concentration within the 300–370 mgI/mL range is generally guided by institutional contracting and injector compatibility rather than a strong protocol-specific preference, since the fixed 110 mL volume and 4.0 mL/s flow rate are calibrated to deliver an adequate iodine flux across this entire concentration range. Departments transitioning to a higher-concentration agent should re-verify that the resulting iodine delivery rate remains appropriately matched to the fixed 50-second enteric delay, since a meaningfully higher iodine flux could, in principle, shift peak mural enhancement earlier than the protocol’s fixed timing assumes, particularly in patients with a hyperdynamic circulation.

Radiation dose and reference levels

Because many IBD patients are diagnosed in adolescence or early adulthood and require repeated surveillance imaging over decades, radiation dose stewardship in CT enterography is a particularly important responsibility — arguably more so than in many other body CT applications. A patient diagnosed with Crohn’s disease at age 18 who undergoes a surveillance CT enterography study every two to three years, in addition to imaging for acute flares or complications, can plausibly accumulate a meaningful cumulative effective dose over a fifty-year disease course. This longitudinal perspective should inform every dose-related decision made at the point of protocol design, not only the single-study dose metrics reported below.

Five dose reduction strategies for CT enterography

• Single-phase acquisition by default. Reserve multiphase imaging for specific indications such as suspected GI bleeding or vascular complication rather than routine IBD surveillance. Each additional phase roughly doubles the cumulative dose for that visit, so the default protocol should always start from the assumption that a single, well-timed acquisition is sufficient unless a specific clinical question requires otherwise.
• Automatic exposure control with size-specific modulation. Tube current modulation tailored to body habitus avoids unnecessary dose in smaller patients while preserving diagnostic image quality in larger ones. Modern modulation algorithms adjust both angularly around each rotation and longitudinally along the length of the scan, which is particularly relevant in enterography given the substantial difference in attenuation between the upper abdomen and the pelvis.
• Deep learning or advanced iterative reconstruction. Allows tube current reduction of 30–50% relative to filtered back-projection while maintaining contrast-to-noise ratio^[27]. Because these algorithms are applied at the reconstruction stage rather than requiring new hardware, they represent one of the most cost-effective dose reduction levers available to departments operating existing scanner fleets.
• Judicious use of MR enterography in eligible patients. Younger patients, pregnant patients, and those requiring frequent serial follow-up should be triaged to MR enterography where local expertise and availability allow. A clear institutional pathway for this triage decision — rather than leaving it to ad hoc judgment at the point of ordering — meaningfully reduces cumulative lifetime dose across an IBD population.
• Protocol-specific kVp selection. Lower kVp settings in smaller adults and pediatric patients improve iodine conspicuity at reduced dose, consistent with ICRP optimization principles. Pairing a lower kVp setting with the spectral or photon-counting platforms discussed earlier compounds the benefit, since lower-energy virtual monoenergetic reconstructions further amplify iodine signal without requiring any additional acquisition dose.

Taken together, these five strategies are not mutually exclusive — in practice, the greatest cumulative dose reduction is achieved by layering automatic exposure control, advanced reconstruction, and appropriate kVp selection within every single CT enterography acquisition, while reserving the modality-substitution strategy (MR enterography) for the specific patient subgroups where it offers the clearest long-term benefit.

These strategies are aligned with the dose optimization frameworks published in European Commission Radiation Protection 185, the American Association of Physicists in Medicine (AAPM) size-specific dose estimate methodology^[27], and the International Commission on Radiological Protection (ICRP) “as low as reasonably achievable” (ALARA) principle.

Routine departmental dose auditing — comparing actual CTDIvol and DLP values for enterography studies against the locally adopted diagnostic reference levels on a regular basis — provides an objective check on whether protocol drift has occurred over time, particularly after a scanner software upgrade, a change in reconstruction settings, or staff turnover. Outlier cases, whether unexpectedly high or unexpectedly low for patient size, are worth individually reviewing, since both directions can signal a protocol or technique issue: unexpectedly high values may reflect a forgotten manual override of automatic exposure control, while unexpectedly low values in a larger patient may signal underexposure with associated image noise that could compromise the subtle mural and mesenteric findings central to this examination.

Top 10 pathologies detected on CT enterography

The diagnostic yield of the CT enterography protocol spans inflammatory, neoplastic, vascular, and mechanical small bowel disease. The ten entities below represent the most clinically significant findings encountered in routine practice.

Active Crohn’s disease remains the most frequent indication and the most frequent positive finding, but the differential diagnosis for small bowel wall thickening on enterography is genuinely broad, and a disciplined radiologist must actively consider — and actively exclude — the other nine entities on this list before anchoring on an inflammatory diagnosis, particularly in a patient without a prior confirmed diagnosis of IBD. Several of these entities share overlapping CT appearances with active Crohn’s disease, which is precisely why HU-based density assessment, multiplanar reformatting, and correlation with the clinical presentation are all required together rather than any single feature in isolation.

Distinguishing Crohn’s disease from ulcerative colitis on cross-sectional imaging

Although both Crohn’s disease and ulcerative colitis fall under the IBD umbrella, their characteristic cross-sectional appearances differ in several reliable ways that a careful reader can use to support — though never to fully replace — endoscopic and histologic confirmation. Crohn’s disease classically demonstrates a discontinuous, “skip lesion” distribution, transmural involvement extending through the full wall thickness into the mesenteric fat, eccentric or asymmetric wall thickening, and a predilection for the terminal ileum. Mesenteric complications such as fistulae, abscesses, and the comb sign are essentially specific to Crohn’s disease in this context and are not expected findings in ulcerative colitis. Ulcerative colitis, by contrast, typically produces continuous, circumferential, symmetric wall thickening confined predominantly to the colon, beginning in the rectum and extending proximally in continuity without skip areas; transmural and mesenteric complications are distinctly uncommon unless severe, fulminant disease has supervened. A patient presenting with colonic-predominant, continuous, symmetric thickening and no mesenteric stranding or comb sign should prompt consideration of ulcerative colitis or another colitis mimicker, even in a patient with a presumptive prior diagnosis of Crohn’s disease, since the distinction has direct implications for surgical planning, as colectomy is curative for ulcerative colitis but not for Crohn’s disease.

Considered together, these ten entities illustrate why CT enterography interpretation cannot be reduced to a single pattern-recognition exercise. The same wall-thickening appearance can represent an entirely benign collapsed loop, a chronic fibrofatty stricture from old disease, an actively inflamed segment requiring therapy escalation, or — far less commonly but with much higher stakes — a small bowel malignancy. Systematic correlation of HU values, enhancement pattern, segment length, and mesenteric findings, combined with the clinical history supplied by the referring physician, is what ultimately separates a confident, accurate report from a hedge-filled one that fails to guide management.

Among the three neoplastic entities discussed above, a useful mental framework distinguishes them by growth pattern and enhancement: adenocarcinoma typically produces a focal, annular, mildly enhancing stricture with abrupt shouldered margins; carcinoid tumor produces a small, avidly enhancing submucosal or mesenteric mass disproportionate to its size, often with a desmoplastic mesenteric reaction visible before the primary tumor itself is identified; and GIST produces a larger, more heterogeneous, often exophytic mass with a comparatively lower likelihood of causing luminal obstruction despite its size. None of these patterns is perfectly specific in isolation, but together with patient age, symptom profile, and any relevant biochemical markers, they substantially narrow the differential before tissue diagnosis is pursued.

Pitfalls for radiographers

Technical execution errors at the scanning stage are uniquely consequential in CT enterography because, unlike many other CT examinations, the diagnostic information depends on a precise interaction between two separately timed contrast agents rather than a single intravenous bolus alone. A technical error that might be a minor inconvenience in a routine abdominal CT — slightly suboptimal bowel distention, for instance — can render an enterography study genuinely non-diagnostic, since the entire purpose of the examination is mural and luminal assessment rather than simple organ visualization.

The primary scanning pitfall in the CT enterography protocol is using barium instead of a neutral oral contrast agent. High-density barium fills the lumen so brightly that it obscures subtle mucosal hyperenhancement and prevents accurate assessment of wall thickness, defeating the entire purpose of the examination. Neutral agents such as Volumen or a mannitol-based solution are required specifically because they expand the lumen without masking the enhancement pattern of the bowel wall itself.

Departments that have successfully reduced the rate of this particular error tend to share a common feature: a standing, protocol-locked order set in the radiology information system that automatically flags any enterography order with the correct neutral oral contrast requirement, rather than relying solely on individual technologist memory or a generic “abdominal CT prep” instruction sheet that may not distinguish enterography from a routine contrast-enhanced abdominal CT.

Pitfalls for radiologists

The primary interpretation pitfall in CT enterography is that poorly distended or collapsed segments of small bowel can simulate pathologic wall thickening and hyperenhancement. A collapsed loop, viewed in cross-section, produces an apparently thick, soft-tissue-attenuation “wall” that can closely mimic active inflammatory disease — a classic source of false-positive Crohn’s disease calls, particularly in the proximal jejunum where distention is often least reliable.^[1],[3]

A further, more subtle source of interpretive error arises from comparing studies performed on different scanner platforms or with different contrast protocols over time, since absolute HU values for “active” enhancement can shift modestly between vendors and reconstruction algorithms. Radiologists performing serial comparison should anchor their assessment on relative change within the same patient — comparing the enhancement of a given segment against that same segment’s own prior appearance and against currently uninvolved bowel in the same study — rather than relying purely on fixed, generic HU thresholds drawn from the literature.

The value of structured reporting templates

Structured, segment-by-segment reporting templates have been advocated specifically to reduce many of the interpretation pitfalls described above, by prompting the radiologist to systematically document distention adequacy, the presence or absence of mural stratification, mesenteric findings, and the involved segment length for every relevant region rather than relying on free-text narrative that can inadvertently omit a structured field^[17]. Departments that have adopted standardized reporting templates for enterography report improved consistency between radiologists and easier longitudinal tracking of disease extent across serial examinations, both of which directly support the referring gastroenterology team’s ability to make confident treatment decisions.

Pitfalls for non-radiology physicians

Referring gastroenterologists, emergency physicians, and surgeons reading the radiology report — or glancing at images themselves — face a different set of pitfalls rooted in incomplete familiarity with enterography-specific appearances. These pitfalls tend to be conceptual rather than purely technical: they arise from treating an imaging report as a standalone diagnostic verdict rather than as one input among several that must be weighed together with biomarkers, endoscopic findings, and the patient’s clinical trajectory.

A recurring theme across all five of these pitfalls is the value of direct communication between the ordering clinician and the radiologist, particularly for atypical presentations or when imaging findings appear discordant with the clinical picture. A brief phone call or secure messaging exchange at the time of report finalization — rather than relying solely on the written impression — frequently resolves ambiguity far more efficiently than a delayed clinic follow-up after a management decision has already been made on an incomplete understanding of the imaging.

Pitfall comparison summary

The three pitfall categories described above operate at different stages of the diagnostic pathway, but they share a common root cause: each represents a point at which an appearance driven by technique or normal variation can be mistaken for genuine pathology, or vice versa. Viewing them side by side helps a multidisciplinary team identify where, within their own local workflow, a similar breakdown might most plausibly occur.

AI and automation in CT enterography

Artificial intelligence tools are increasingly integrated into the CT enterography protocol workflow, from automated bowel segmentation to quantitative scoring of disease activity^[11],[12]. Several FDA-cleared and CE-marked algorithms now support semi-automated measurement of bowel wall thickness, mesenteric fat density, and lesion-by-lesion comparison against prior studies — functions historically performed manually and inconsistently between readers.

Automated bowel segmentation and quantitative scoring

Convolutional and transformer-based deep learning models trained specifically on small bowel CT and MR enterography datasets can now identify and segment individual bowel segments, flag regions of abnormal wall thickness or hyperenhancement, and generate a reproducible numeric severity score analogous to established clinical indices such as the Simple Endoscopic Score for Crohn’s Disease^[13],[14]. Early validation studies suggest these automated scores correlate reasonably well with both endoscopic disease activity and with radiologist consensus grading, although performance still varies meaningfully depending on image quality, the specific algorithm and training dataset used, and the population studied.

Radiomics and texture-based disease characterization

Beyond simple segmentation, radiomic analysis — the extraction of quantitative texture, shape, and intensity features from regions of interest — has shown promise in predicting which patients are likely to achieve mucosal healing on subsequent endoscopy, potentially allowing earlier identification of treatment non-responders who might benefit from earlier therapy escalation^[16]. Multi-task deep learning approaches that simultaneously predict several related outcomes from a single set of extracted features represent an active area of ongoing research rather than settled, widely deployed clinical practice.

Workflow-level automation

Workflow-level automation — including AI-driven protocoling, automated reformat generation, and structured reporting templates — is also reducing technologist and radiologist time burden, particularly valuable given the rising incidence of IBD globally and the growing surveillance imaging volume that follows. Automated protocoling tools can flag an incoming order as a CT enterography request and pre-populate the correct oral and intravenous contrast parameters at the point of scheduling, reducing the risk of the barium-substitution pitfall discussed earlier in this guide by removing reliance on individual staff memory for a less commonly performed protocol.

Current limitations and the role of radiologist oversight

Importantly, current AI tools remain decision-support adjuncts rather than autonomous diagnostic systems. Radiologist oversight remains essential, particularly for nuanced calls such as distinguishing collapsed bowel from true pathology — exactly the pitfall category where pattern-recognition algorithms can themselves be misled by the same distention-dependent appearances that challenge human readers. Most published validation studies to date have been performed on single-institution datasets with limited external validation, and prospective, multi-center outcome data demonstrating that AI-assisted reporting actually changes patient management in a beneficial way remains comparatively limited. Departments adopting these tools should treat them as an additional layer of quality assurance and efficiency rather than a replacement for careful, segment-by-segment radiologist review.

The regulatory landscape for AI tools in gastrointestinal cross-sectional imaging continues to evolve, with a growing but still relatively small number of FDA-cleared and CE-marked algorithms specifically validated for small bowel applications compared with the larger ecosystem of AI tools available for higher-volume indications such as chest CT or mammography. Hospital administrators evaluating a potential AI investment for enterography workflows should request institution-specific or closely comparable validation data from the vendor, rather than relying solely on marketing claims drawn from a different anatomic application or a different patient population, since performance characteristics described for one clinical use case do not necessarily generalize to small bowel disease activity scoring.

Looking ahead, the most promising near-term direction is not a single transformative algorithm but the steady integration of several complementary technologies — photon-counting acquisition, deep learning reconstruction, and AI-assisted quantitative scoring — into a single, coherent enterography workflow. Each technology individually offers an incremental benefit in dose, contrast load, or interpretive consistency; combined, and validated together within a single department’s case mix, they have the potential to meaningfully reduce the cumulative imaging burden experienced by a typical IBD patient over a multi-decade disease course, without sacrificing diagnostic confidence at any individual time point.

Further reading

1. 2026 Worldwide Guidelines for Safe Contrast Media Administration: eGFR Thresholds, Creatinine Levels, Society Recommendations, Saline Hydration Impact, and Pediatric Considerations
2. The Price We Pay for Bubbles in CT and MRI: Understanding Venous Air Embolism in Contrast-Enhanced Imaging
3. 7 Proven Strategies for Optimizing MRI Sequences in 2026
4. Scaling Radiology AI in 2026: Moving from Pilot Projects to Core Infrastructure
5. Radiology Workflow Optimization in 2026: Solving Staff Shortages with AI and Agentic Systems

Conclusion

The CT enterography protocol remains the workhorse cross-sectional technique for evaluating suspected and established inflammatory bowel disease, offering full-thickness assessment of the bowel wall and mesentery that endoscopy alone cannot provide. Diagnostic success depends on a precise combination of large-volume neutral oral contrast distention, a carefully timed 50-second intravenous bolus, and disciplined image review across all ten major pathology categories — from active Crohn’s disease and ulcerative colitis through to small bowel adenocarcinoma, carcinoid tumor, GIST, celiac disease, intussusception, Meckel’s diverticulum, ischemia, and radiation enteritis.

The three-tier pitfall framework outlined in this guide — scanning errors rooted in oral contrast selection, interpretation errors rooted in distention-dependent pseudo-pathology, and clinical errors rooted in over-interpreting qualitative imaging signs — provides a practical checklist for radiographers, radiologists, and referring physicians alike. Applied consistently, this framework reduces both false-positive disease escalation and missed penetrating or neoplastic complications, supporting safer, more reproducible IBD care across the full patient journey.

As dual-energy and photon-counting platforms become more widely available, and as deep learning reconstruction and AI-assisted quantification tools mature beyond single-institution validation, the next several years are likely to bring further reductions in cumulative radiation exposure alongside improved objectivity in disease activity scoring. None of these technical advances, however, substitute for the fundamentals covered throughout this guide: adequate bowel distention, correct contrast agent selection, accurate timing, and a systematic, segment-by-segment review pattern applied consistently to every study. Departments that institutionalize these fundamentals — through locked protocol templates, structured reporting, and ongoing multidisciplinary communication between radiology and referring gastroenterology teams — are best positioned to deliver consistently diagnostic, clinically actionable CT enterography studies at scale.

Ultimately, the value of a CT enterography study is measured not by technical sophistication for its own sake but by whether it changes — or correctly confirms — the clinical plan for the individual patient in front of the requesting physician. A technically excellent study, well distended and correctly timed, read by a radiologist applying a systematic segment-by-segment approach and reported in a structured, unambiguous format, gives the gastroenterology and surgical teams exactly what they need: a clear picture of disease distribution, activity, and complication status on which to base the next step in that patient’s care.

References